search

Cardio Diagnostics

Claimed vendor Claimed
Reviews pending

Cardio Diagnostics Products (7)

   
search

Cardiovascular Health

search

Business Intelligence

search

Claims Analytics

search

Data Analytics

search

Data Dashboard

search

Health Risk Assessment

search

High Tech Imaging and Testing

Product Description

Epi+Gen CHD and PrecisionCHD<br /> <br /> Cardio's DNA tests measure DNA Methylation and genetic information. The DNA methylation biomarkers change when the risk of heart disease has increased or decreased, and we can measure those changes and link them to the risk factors that need to be addressed. Employers... Show More

About this product

×
Epi+Gen CHD and PrecisionCHD

Cardio's DNA tests measure DNA Methylation and genetic information. The DNA methylation biomarkers change when the risk of heart disease has increased or decreased, and we can measure those changes and link them to the risk factors that need to be addressed. Employers can select and optimize for Cardiovascular health programs and point solutions based on the factors we identify in their employee population, including a section on suggested programs tailored to their employee risks.

Min. Group Size

20 eligible

Lives Serviced

40,250

Average Cost

Average Cost is Locked

66 RFI Questions RFI questions

RFI questions number is Locked

15 Specific Questions Specific Questions tooltip

Lock

Product Features

✓

CAD/Hypertension Devices  

✓

CAD/Hypertension support specialists  

✓

Individualized treatment plans 

✓

Heart disease prevention programs

✓

Heart disease tracking tools

Show All Features

Product Features

×

Cardio Diagnostics Info

Founded:

05/2017

Funding Summary:

Not Provided

Location:

Chicago, IL

Links:

Employees:

Not Provided
The company's solutions: The only blood test-of-its-kind (Epi+Gen CHD) in the world to offer personalized (epigenetics-based) insights into coronary heart disease drivers and assess the risk of a heart attack in the next three years. This risk assessment test evaluates... Show More

About this vendor

×
The company's solutions:

The only blood test-of-its-kind (Epi+Gen CHD) in the world to offer personalized (epigenetics-based) insights into coronary heart disease drivers and assess the risk of a heart attack in the next three years. This risk assessment test evaluates five single nucleotide polymorphisms (SNPs) and three DNA methylation markers in genomic DNA isolated from human peripheral whole blood specimens.

The only blood test-of-its-kind in the world (PrecisionCHD) to detect the presence of coronary heart disease (epigenetics-based).
Both tests are accompanied by Actionable Clinical Intelligence (a personalized report about specific drivers of coronary heart disease) and HeartRisk which is an Employer CVD Risk Intelligence platform (an employer-specific dashboard reviewing population health CVD statistics in their industry along with aggregated employee CHD risk insights to better allocate benefits resources).

Cardio Diagnostics Clients

Cardio Diagnostics Alternatives

Streamline Your Vendor Selection

Our team of experts can help you choose the right vendor for your business. Let’s get in touch!